Alison Dent

Alison Dent is a seasoned clinical specialist with extensive experience in oncology and specialty pharmaceuticals. Currently, Alison serves as a Senior Clinical Specialist at Puma Biotechnology, Inc., focusing on targeted treatments for early-stage and metastatic HER2+ breast cancer. Prior to this role, Alison worked at Bayer Pharmaceuticals as an Oncology Specialty Consultant, where responsibilities included managing treatments for hematology and site-agnostic solid tumors. Earlier experience includes a position as a Hospital Specialty Manager at Arbor Pharmaceuticals, overseeing a novel intracranial carmustine implant for neuro-oncology patients. Alison's career in the pharmaceutical industry began as a Sales Representative at Takeda Pharmaceuticals, with a background in diabetes care at Novo Nordisk A/S. Alison holds a degree in Applied Exercise Physiology from Texas A&M University.